genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2022
Oncolytic virotherapy
Cancer
Oncolytic Virotherapy Combined with Immunotherapy Tackles Resistant Cancer
Cancer
The Life Oncolytic, with Stephen Russell
Cancer
Novel Oncolytic Virus-Based Treatment Extends Survival in Pancreatic Cancer Models
News
Max Planck Partners with Themis Bioscience to Develop Oncolytic Virotherapies
News
Interaction of Oncolytic Viruses Observed with Both Tumor and Healthy Cells
Drug Discovery
Boehringer Ingelheim to Co-Develop ViraTherapeutics’ Oncolytic Virus Platform, Candidate
Cancer
Enlisting Viruses in the Fight against Cancer
News
Virotherapy as a Key to Cancer Treatment
Cancer
Oncolytic Virus Therapy Firms Merge
Cancer
Cold Genesys Buys BioSante’s Oncolytic Virus Technology
Scroll Up
Scroll Up
